<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"familial non-medullary thyroid cancer":1,
"family screening":1,
"paediatric":1,
"papillary thyroid cancer":14,
"ultrasound":14,
"differentiated thyroid carcinoma":5,
"lymph node metastasis":9,
"lymph node posterior to right recurrent laryngeal nerve":2,
"3D matrix":1,
"FTC-133 cells":1,
"LRP-1":1,
"collagen type I":1,
"migration":3,
"Cytological sub-categories":1,
"Indeterminate thyroid nodule":2,
"Thyroid nodule clinical risk":1,
"Thyroid nodule management":1,
"navigation program":1,
"perioperative care":1,
"satisfaction":1,
"thyroid cancer":61,
"Classification":1,
"FFPE tissue":1,
"Mass spectrometry imaging":2,
"Molecular signature":1,
"Laser":1,
"Minimally invasive treatment":1,
"Papillary thyroid microcarcinoma":1,
"Thermal ablation":2,
"Bilateral axillo-breast approach":1,
"Firefly technology":1,
"Indocyanine green fluorescence":1,
"Near infrared":1,
"Parathyroid glands":3,
"Robotic thyroidectomy":3,
"DICER1 germline mutation":1,
"DICER1-syndrome":1,
"Embryonal rhabdomyosarcoma":1,
"Focal nodular hyperplasia":1,
"Frameshift":1,
"Medulloepithelioma":1,
"Pleuropulmonary blastoma":2,
"Renal cysts":1,
"BRAF V600E mutation":2,
"Thy3a":1,
"Thy3f":1,
"Thy4":1,
"Cancer":16,
"Proteomics":2,
"Thyroid":44,
"Tissue microarray":1,
"Biopsy, fine-needle":1,
"Biopsy, large-core needle":1,
"Carcinoma, renal cell":1,
"Neoplasm metastasis":1,
"Thyroid gland":4,
"Ultrasonography":20,
"HER2":1,
"Lung adenocarcinoma":3,
"MUC4":1,
"Prognosis":17,
"Smoking status":1,
"Breast cancer":19,
"Clinical trial":1,
"Postoperative radiation therapy":1,
"differentiated thyroid cancer":11,
"dosimetry":2,
"imaging":3,
"radionuclide therapy":1,
"radiopharmaceuticals":1,
"SERCA":1,
"apoptosis":7,
"breast cancer cells":1,
"calcium":2,
"resveratrol":2,
"Family history":1,
"Systemic review":1,
"Endoscopic surveillance":1,
"Familial adenomatous polyposis":1,
"Gastric cancer":3,
"Screening":4,
"annual percent change":1,
"average annual percent change":1,
"early estimates of cancer incidence rates":1,
"population-based registry data":1,
"registry-specific delay-adjustment":1,
"job-exposure matrix":1,
"occupational exposure":1,
"(18)F-FDG PET/CT":1,
"(18)F-FDG PET/TC":1,
"Carcinoma de células escamosas":1,
"Positron emission tomography":3,
"Squamous cell carcinoma":5,
"Tiroides":1,
"Tomografía por emisión de positrones":1,
"Ewing sarcoma":1,
"childhood cancer survivors":1,
"chronic health conditions":1,
"late mortality":1,
"treatment-related complications":1,
"Curcumin":1,
"G2/M arrest":1,
"NF-κB":2,
"Acromegaly":1,
"Inappropriate TSH secretion":1,
"Pituitary tumor":2,
"TSHoma":1,
"Thyroid carcinoma":13,
"CAFs":1,
"Exosomes":1,
"PBX3":1,
"Tumourigenesis":1,
"miR-320a":1,
"Follicular thyroid carcinoma":3,
"Recurrence":8,
"Thyroidectomy":17,
"BRAF mutation":2,
"fluorodeoxyglucose F18":1,
"thyroid neoplasms":19,
"thyroid neoplasm":4,
"genomics":1,
"hereditary endocrine neoplasia":1,
"medullary thyroid cancer":4,
"neoplasia":1,
"paraganglioma":3,
"phaeochromocytoma":1,
"tumour heterogeneity":1,
"Atypical presentation":1,
"Metastasis":6,
"Survival":6,
"Bethesda":2,
"adequacy":2,
"atypia":1,
"fine-needle aspiration":8,
"nondiagnostic":1,
"Computer-assisted":1,
"Diagnosis":9,
"(99m)Tc-MIBI scintigraphy":1,
"Adenoma quístico paratiroideo":1,
"Cystic parathyroid adenoma":1,
"Gammagrafía (99m)Tc-MIBI":1,
"Hiperparatiroidismo primario":1,
"Primary hyperparathyroidism":2,
"head and neck ultrasound":2,
"pitfalls":1,
"sonography":4,
"Follicular variant":2,
"Infiltrative":1,
"Microcalcifications":1,
"Papillary":2,
"head and neck":1,
"Everolimus":2,
"Neuroendocrine tumours":2,
"Therapy":2,
"mTOR inhibitors":1,
"Papillary thyroid carcinoma":51,
"ROLL":1,
"fresh cadaver":1,
"otolaryngology education":1,
"thyroid biopsy":1,
"thyroid mass":1,
"AUS/FLUS":3,
"Bethesda III":1,
"malignancy":2,
"subcategorization":1,
"thyroid nodule":17,
"IL-1β":1,
"inflammation":2,
"non-medullary thyroid cancer":1,
"radioactive iodide therapy":1,
"T cell receptors":1,
"high-throughput sequencing":1,
"multifocal papillary thyroid carcinoma":1,
"neoantigens":1,
"tumour-infiltrating lymphocytes":1,
"Chemoradiation":1,
"Dysphagia":1,
"Prophylactic exercises":1,
"Quality of life":3,
"Swallowing":2,
"external beam radiation therapy":1,
"radioactive iodine":3,
"stage IV":1,
"papillary carcinoma":7,
"recurrence pattern":1,
"relapse":2,
"remission":1,
"central compartment":1,
"elective":2,
"extrathyroidal extension":4,
"lymph node dissection":1,
"lymph node metastases":3,
"papillary thyroid cancer (PTC)":1,
"prophylactic":1,
"therapeutic":1,
"Mucosal melanoma":2,
"Oropharynx":1,
"Palatine tonsil":1,
"Primary tonsillar melanoma":1,
"Tonsillar melanoma":1,
"anaplastic thyroid carcinoma":6,
"clinical trials":2,
"multidisciplinary care":1,
"quality improvement":1,
"radioiodine":2,
"recombinant Human TSH":1,
"salivary":1,
"sialadenitis":1,
"Superb Micro-Vascular Imaging":1,
"vascularity":1,
"active surveillance":1,
"repeated FNA":1,
"surgery":2,
"biopsy/needle aspiration":1,
"cytology":6,
"kinetics":1,
"lung":3,
"response evaluation criteria in solid tumors":1,
"Caspase activation":1,
"Human papillary thyroid cancer":1,
"Myricetin":1,
"anaplastic":1,
"lenvatinib":7,
"treatment":5,
"SEER program":1,
"inflammatory breast cancer":1,
"molecular subtypes":1,
"outcomes":1,
"diagnostic performance":1,
"indeterminate thyroid nodules":5,
"meta-analysis":8,
"systematic review":1,
"thyroid FNA cytology":1,
"Characteristics and pathology of human cancer":1,
"microRNA/non-coding RNA respiratory organ":1,
"oncogenes and tumor-suppressor genes":1,
"Mito-CP":1,
"Mito-Q":1,
"cabozantinib":6,
"drug resistance":2,
"medullary thyroid carcinoma":13,
"mitochondria":3,
"vandetanib":2,
"American Thyroid Association (ATA) guidelines":1,
"epidemiology":5,
"international":1,
"survey":2,
"recurrent laryngeal nerve":2,
"superior parathyroid":1,
"colorectal cancer":1,
"expression":1,
"kidney-type glutaminase (GLS1)":1,
"knockdown":1,
"pyruvate kinase M2 type (PKM2)":1,
"Axillary approach":1,
"Gas inflation":1,
"Single incision endoscopic thyroidectomy":1,
"cancer panel":1,
"fusion gene":1,
"papillary thyroid carcinoma (PTC)":2,
"somatic mutation":1,
"Core needle biopsy":2,
"Fine needle aspiration biopsy":2,
"Hematoma":2,
"good cancer":1,
"patient perspectives":1,
"qualitative research":1,
"Immunotherapy":3,
"Pembrolizumab":2,
"Programmed cell death 1 receptor":1,
"Squamous cell carcinoma of the head and neck":1,
"U S Food and Drug Administration":1,
"PD-1":1,
"immune checkpoint inhibitor":1,
"nivolumab":3,
"painless thyroiditis":1,
"thyrotoxicosis":1,
"Sanger sequencing":2,
"fine needle cytology":2,
"genetic testing":1,
"multiplex PCR":1,
"Cell migration":1,
"Long intergenic noncoding RNA LINC00312":1,
"MicroRNA-197-3p":1,
"invasion and migration":1,
"proliferation":6,
"diffuse large B-cell lymphoma":1,
"incidence":4,
"lymphoma":1,
"second primary malignancy":1,
"biomarkers":2,
"long non-coding RNA":1,
"CEA":1,
"Calcitonin":4,
"Follicular neoplasm":2,
"FoxA1":1,
"BRAF":4,
"Occult primary thyroid carcinoma":1,
"Poorly differentiated thyroid carcinoma":2,
"Epstein-Barr virus":1,
"Polymerase Chain Reaction":1,
"AJCC":1,
"Head and neck cancer":2,
"Stage classification":1,
"TNM":1,
"UICC":1,
"Three Mile Island":1,
"next-generation sequencing":1,
"radiation":2,
"SSTR":1,
"VEGF":1,
"pituicytoma":2,
"targeted therapy":4,
"CRP C-reactive protein":1,
"DII Dietary Inflammatory Index":1,
"ER oestrogen receptor":1,
"PR progesterone receptor":1,
"Case–control studies":1,
"Dietary Inflammatory Index":1,
"A to G mutation":1,
"RAS mutation":1,
"error-prone DNA polymerase":1,
"mutational mechanism":1,
"oxidative stress":2,
"Bim":1,
"biomarker":7,
"luminal A":1,
"microRNA-451":1,
"EPIC":1,
"cohort":1,
"fish":2,
"intake":1,
"High grade":1,
"Meningioma":1,
"Tumor-to-tumor metastasis":1,
"CD20":1,
"pediatrics":1,
"recurrence-free survival":1,
"Atypical histiocytoid cells":1,
"Cyst":1,
"Histiocytes":1,
"Hobnail":1,
"Renal cell":1,
"CABOSUN":1,
"MET":1,
"METEOR":1,
"RCC":1,
"renal cell carcinoma":2,
"Cushing disease":1,
"Cushing syndrome":1,
"adrenal adenoma":1,
"adrenocortical carcinoma":1,
"adrenocorticotropic hormone–independent macronodular adrenal hyperplasia":1,
"pituitary adenoma":4,
"primary pigmented nodular adrenal disease":1,
"EMT":1,
"invasion":5,
"lncRNA TUG1":1,
"miR-145":1,
"clinicopathological characteristics":1,
"pediatric papillary thyroid cancer":1,
"Tenascin-C":1,
"extracellular matrix":1,
"lung cancer":4,
"quantitative proteomics":1,
"tumor microenvironment":1,
"Inhibin beta A":1,
"adjuvant chemotherapy":1,
"Infantile hepatic hemangioendothelioma":1,
"methylprednisolone":1,
"propranolol":1,
"albumin/globulin ratio":1,
"laryngeal squamous cell carcinoma":1,
"prognostic marker":1,
"Radiofrequency ablation":4,
"Technique":1,
"Thyroid nodules":11,
"Goiter":4,
"thyroid-stimulating hormone":1,
"Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography":1,
"renal cell cancer":1,
"tracheal metastasis":1,
"Glucose Tolerance":1,
"Iodine":2,
"Pancreas":1,
"Radioactive":1,
"Sodium-Iodide Symporter":1,
"DEGs":1,
"Enrichment analysis":1,
"Interaction network":1,
"JUN":1,
"PTC":4,
"thyroid autoantibody":1,
"F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography":1,
"I-131 therapy":1,
"lung metastasis":2,
"metabolic tumor volume":1,
"F-18-fludeoxyglucose positron emission tomography/computed tomography":1,
"Ga-68 DOTANOC positron emission tomography/computed tomography":1,
"Hurthle cell neoplasm":1,
"Lu-177 DOTATATE":1,
"peptide receptor radionuclide therapy":1,
"British Thyroid Association 2014 classification":1,
"Clinical evaluation":1,
"Outcome":3,
"Bisphenol A":2,
"endocrine disrupting chemical":1,
"iodine excess intake":1,
"nodular goiter":1,
"elderly":1,
"hypertension":1,
"Overdiagnosis":1,
"Socioeconomic status":1,
"Well-differentiated thyroid cancer":2,
"Hypophysitis":1,
"Immune-related adverse events":1,
"Ipilimumab":2,
"Melanoma":1,
"Thyroiditis":1,
"Berberine":1,
"High glucose":1,
"autophagy":2,
"beclin-1":1,
"microtubule-associated protein 1 light chain 3":1,
"nursing care":1,
"radiotherapy":1,
"vertebral metastases":1,
"Amyotrophic lateral sclerosis":1,
"Brugada syndrome":1,
"Cardiac arrest":1,
"endocrine cancer":2,
"oncology":1,
"thyroid disease":4,
"MAPK":1,
"MMP2":1,
"Trop2":1,
"Mitochondrial ribosomal protein S23":1,
"hepatocellular carcinoma":5,
"Capsule invasion":1,
"Central lymph node dissection":1,
"Central lymph node metastasis":1,
"Solitary papillary thyroid microcarcinomas":1,
"Fourier transform infrared microscopy":1,
"Scintigraphy":1,
"T/B ratio":1,
"Thallium":1,
"GLUT1":1,
"KRAS":1,
"glutathione":1,
"ketogenic diet":1,
"metformin":1,
"vitamin C":1,
"BCPAP":1,
"KI":1,
"YAP":1,
"cell cycle arrest":1,
"immunohistochemistry":11,
"25 OH vitamin D":1,
"ALP":1,
"BMD":1,
"DEXA":1,
"T score":1,
"TSH":3,
"Z score":1,
"corrected calcium":1,
"ionized calcium":1,
"C-reactive protein":1,
"neutrophil-lymphocyte ratio":1,
"platelet-lymphocyte ratio":1,
"Retropharyngeal lymph node":1,
"Transoral surgery":1,
"Autoimmune thyroiditis":1,
"Thyroid cytology":1,
"Fine needle aspiration cytology":1,
"Aberrant thyroid inclusions":1,
"benign epithelial inclusions":1,
"cervical lymph nodes":1,
"metastatic deposits":1,
"EWSR1-ATF1":1,
"Hyalinizing clear cell carcinoma":1,
"Molecular pathology":1,
"Salivary gland tumors":1,
"driver genes":1,
"integrative data":1,
"protein interaction network":1,
"AKT2":1,
"let-7a":1,
"tumor growth":1,
"PCNA":1,
"estrogen receptor α":2,
"iodine excess":1,
"Autoimmunity":1,
"Graves’":1,
"Mean platelet volume":1,
"disease":2,
"National Health Insurance":1,
"Taiwan Cancer Registry":1,
"survival outcome":1,
"fine needle aspiration":6,
"miR-324-5p":1,
"RAI refractory":1,
"sorafenib":4,
"sunitinib":1,
"Magnetic Resonance Imaging":2,
"Ovary":1,
"Teratoma":1,
"Urogenital neoplasms":1,
"Saudi Arabia":1,
"cervical lymph nodal metastasis":1,
"occult primary sites":1,
"carbon nanoparticle":1,
"lymph node excision":1,
"fine needle":1,
"meta analysis":1,
"Carcinoma":4,
"Folliculo-stellate cell":1,
"TTF-1":3,
"pituicyte":1,
"pituitary":1,
"spindle cell oncocytoma":1,
"Thyroid transcription factor-1":3,
"cytokeratin 20":1,
"cytokeratin 5/6":1,
"estrogen receptors":1,
"metastatic lung tumor":1,
"urothelial neoplasm":1,
"Graves’ disease":2,
"Throid hemiagenesis":1,
"Glomus tumors":1,
"complication":2,
"head and neck surgery":2,
"IL-8":1,
"polymorphism":3,
"TCGA":1,
"microRNA-129":1,
"signaling pathways":1,
"target gene":1,
"Hyalinizing trabecular tumor":1,
"N-ras mutation":1,
"thyroid tumor":2,
"Cowden syndrome":2,
"PTEN":2,
"PTEN hamartoma tumor syndrome":1,
"Sistrunk’s procedure":1,
"Thyroglossal cyst":1,
"Total thyroidectomy":2,
"aggressive variant":1,
"columnar variant":1,
"diffuse sclerosing variant":1,
"tall cell variant":2,
"Cause of detection":1,
"ACTH = adrenocorticotropic hormone":1,
"DI = diabetes insipidus":1,
"EOR = extent of resection":1,
"FSH = follicle-stimulating hormone":1,
"GH = growth hormone":1,
"GTR = gross-total resection":1,
"IGF-1 = insulin-like growth factor 1":1,
"LH = luteinizing hormone":1,
"PRL = prolactin":1,
"TSH = thyroid-stimulating hormone":1,
"adenoma":1,
"craniotomy":1,
"endonasal endoscopic":1,
"pituitary surgery":1,
"reoperation":1,
"skull base":1,
"transsphenoidal":1,
"Indeterminate":2,
"TIRADS":1,
"Autofluorescence":1,
"Near-infrared light":1,
"Parathyroidectomy":1,
"aspiration cytology":2,
"micropapillary growth":1,
"small papillary cluster":1,
"solid variant":2,
"Benign thyroid nodule":1,
"Complications":2,
"Recurrent thyroid cancer":1,
"CYTOPATHOLOGY":3,
"exercise-induced arterial hypoxemia":1,
"hypothyroidism":3,
"lung fibrosis":1,
"radioiodine therapy":6,
"Cardiovascular risk":1,
"NT-proBNP":1,
"Anti-thyroglobulin":2,
"Thyroglobulin":4,
"NIFTP":2,
"molecular":2,
"variant":1,
"central neck dissection":2,
"ectopic nodal metastasis":1,
"lateral neck dissection":1,
"nodal metastasis":2,
"Epstein–Barr virus infection":1,
"Herpesvirus":1,
"Viral load":1,
"ACTH":1,
"T -cell":1,
"lymphoblastic lymphoma/leukemia":1,
"Metastatic lymph node":1,
"Radiofrequency ablation (RFA)":1,
"metastatic thyroid cancer":1,
"multikinase inhibitor (MKI) therapy":1,
"overall survival (OS)":1,
"radioactive iodine-refractory thyroid cancer":1,
"structural doubling time":1,
"Anterior commissure":1,
"Fetus":1,
"Human larynx":1,
"Thyroid cartilage":2,
"Vocal folds":1,
"Africa":1,
"blacks":1,
"non-Hispanic":1,
"proportional incidence ratio":1,
"sub-Saharan":1,
"hobnail variant":1,
"IMMUNOCYTOCHEMISTRY":1,
"NEOPLASMS":2,
"fine needle aspiration (FNA)":1,
"micronuclei":1,
"nuclear buds":1,
"Hürthle cell variant":1,
"neck mass":2,
"parotid gland":1,
"5-aza-2′-deoxycytidine":1,
"NGFR":1,
"mTOR":1,
"neurotrophin pathway":1,
"Hashimoto thyroiditis":2,
"Hyperthyroidism":4,
"Hypothyroidisms":1,
"Mammographic density":1,
"precision":1,
"radionuclide":1,
"Polidocanol injection":1,
"Predominantly cystic thyroid nodules":1,
"Sclerotherapy":1,
"lymph node":3,
"mouse":1,
"double slide view":1,
"follicular neoplasm/suspicious for follicular neoplasm":1,
"interobserver reproducibility":1,
"second opinion":1,
"thyroid fine needle aspirates":1,
"endoscopic thyroidectomy":2,
"minimally invasive surgery":1,
"retroauricular thyroidectomy":1,
"transaxillary":1,
"DTC":1,
"comorbidities":1,
"population based":1,
"thyroid symptoms":1,
"BMT":1,
"brain tumors":1,
"endocrinology":2,
"late effects of cancer treatment":1,
"outcomes research":1,
"2-hydroxylated estradiol":1,
"4-hydroxylated estradiol":1,
"UDP-glucuronosyltransferase (UGT)":1,
"estradiol":1,
"estrogen homeostasis":1,
"estrogen metabolism":1,
"noninvasive follicular tumor with papillary like nuclear features":1,
"papillae":1,
"cost-effectiveness":1,
"radioiodine refractory":1,
"value-based":1,
"Endocrine system":1,
"Fine-needle aspiration biopsy":1,
"Gene mutation":2,
"circulating biomarkers":1,
"surveillance":1,
"atypia of undetermined significance":1,
"biopsy":2,
"fine-needle":1,
"neoplasm":1,
"case-control":1,
"exposure":1,
"adolescent and young adult":1,
"pediatric":2,
"population-based":2,
"gene classifier":1,
"in vitro diagnostic test":1,
"qPCR":2,
"Biological dosimetry":1,
"Chromosomal aberrations":1,
"Dose-rate effect":1,
"Elastography":3,
"Epithelial–mesenchymal transition":1,
"HNF4α":1,
"Liver stem cells":1,
"Snail":1,
"Tg737":1,
"18F–DOPA":1,
"18F–FDG":1,
"68Ga-DOTANOC":1,
"68Ga-DOTATATE":2,
"68Ga-DOTATOC":1,
"Foregut-NET":1,
"Hindgut-NET":1,
"Hyperinsulism in infants":1,
"Midgut-NET":1,
"Neuroendocrine neoplasms":2,
"Pet/Ct":1,
"Pheochromoacytoma":1,
"Thyroid medullary cancer":1,
"5,10,15,20-Tetrakis(4-hydroxyphenyl)-21H,23H-porphine (PubChem CID: 5481276)":1,
"Drug delivery":1,
"PHBV":1,
"PLGA":1,
"Photodynamic therapy":1,
"Photosensitizer":1,
"Polymer-lipid-PEG nanoparticles":1,
"PIM1":1,
"Physcion 8-O-β-glucopyranoside":1,
"Migration and invasion":1,
"Mitochondrial membrane potential":1,
"Niclosamide":1,
"cardiovascular mortality":1,
"ovarian cancer":1,
"women's health":1,
"Cancer de la thyroïde":1,
"Case-control study":1,
"Dosimetric reconstruction":1,
"Perception des risques":1,
"Radiation risk perception":1,
"Reconstructions dosimétriques":1,
"Étude cas-témoins":1,
"liquid-based cytology":1,
"malignancies":1,
"malignant histotypes":1,
"pediatric patients":1,
"thyroid lesions":1,
"Ductal invasive breast carcinoma":1,
"Image analysis":1,
"Thyroid hormone receptor alpha":1,
"Tissue expression":1,
"Tri-iodothyronine":1,
"Laryngectomy":1,
"Tyrosine kinase inhibitors":2,
"anaplastic thyroid cancer":3,
"differentiated":1,
"medullary":1,
"multikinase inhibitors":1,
"Adhesion molecule":1,
"VSIG1":1,
"immunoglobulin superfamily":1,
"microRNA":1,
"nodules":1,
"iodine-131":2,
"second primary cancer":1,
"Papillary cancer":2,
"Prediction":1,
"TERT promoter":1,
"Bethesda System":1,
"Cyst fluid only":1,
"Non-diagnostic":1,
"Unsatisfactory":1,
"Cardiac risk":1,
"Pharmacodynamics exposure–response":1,
"Pharmacokinetics":2,
"QTc":1,
"subxiphoid approach":1,
"thoracoscopic surgery":1,
"thymectomy":1,
"video-assisted thoracic surgery":1,
"RET inhibitors":1,
"hit-to-lead":1,
"kinases":1,
"pyridines":1,
"pyrimidines":1,
"Long noncoding RNA H19":1,
"MicroRNA Let7a":1,
"familial":1,
"ATA guidelines":2,
"thyroid ultrasound":2,
"Early tumor shrinkage":1,
"ALDH1":1,
"CD133":1,
"CD24":1,
"CD44":1,
"Cancer stem cell":2,
"Minimally invasive":1,
"Robotic parathyroidectomy":1,
"TOETVA":1,
"TONS":1,
"TORT":1,
"Transoral endoscopic thyroidectomy vestibular approach":1,
"Transoral thyroidectomy":1,
"Mortality":3,
"Neoplasm staging":1,
"TNM staging":2,
"Cholangiocarcinoma":1,
"Hepatitis C virus":1,
"Oral squamous cell cancer":1,
"Pancreatic adenocarcinoma":1,
"Renal/kidney cancer":1,
"Endocrine":1,
"Extrahepatic manifestations":1,
"Hepatitis C":2,
"Idiopathic thrombocytopenic purpura":1,
"Pulmonary":1,
"Chemical labeling":1,
"DNA and RNA formylation":1,
"In-tube solid-phase microextraction":1,
"Ultra high performance liquid chromatography - tandem mass spectrometry analysis":1,
"Computer vision":1,
"Convolutional neural network":1,
"Deep learning":1,
"Fine-tuning":1,
"Machine learning":1,
"Chimeric A2M-ALK gene":1,
"Fetal lung interstitial tumor":1,
"Inflammatory myofibroblastic tumor":1,
"Reverse-transcription polymerase chain reaction":1,
"Follicular":1,
"Mass spectrometry":2,
"Therapeutic target":1,
"Dental artifact":1,
"Dual-energy CT":1,
"Head and neck squamous cell carcinoma":1,
"Lymphadenopathy":1,
"Material decomposition iodine maps":1,
"Spectral Hounsfield unit attenuation curves":1,
"Thyroid cartilage invasion":2,
"Virtual monochromatic images":1,
"DNA damage":1,
"Zucker rat":1,
"obesity":1,
"γ-H2AX":1,
"Taste alteration":1,
"antidepressants":1,
"dysgeusia":1,
"Adverse events":1,
"endocrine toxicity":1,
"immune checkpoint inhibitors":2,
"thyroid dysfunction":1,
"Extreme learning machine":1,
"Feature selection":1,
"Medical diagnosis":1,
"Sonographic features":1,
"Bladder":1,
"NEC":1,
"pathological features":1,
"cancer susceptibility":1,
"clonal selection":1,
"personalized medicine":1,
"tumor heterogeneity":1,
"Composite pheochromocytoma/paraganglioma":1,
"Ganglioneuroma":1,
"MEN 2":1,
"farnesoid X receptor":1,
"thyroid neoplasia":1,
"calcium and bone":1,
"general surgery":1,
"SHBG":1,
"endogenous sex hormone":1,
"male":1,
"metastases":2,
"molecular biology":1,
"oncogenes":2,
"Chinese patients":2,
"breast metastasis":1,
"gastric carcinoma":1,
"BRAF V600E":2,
"Fas/FasL":1,
"SW579":1,
"human thyroid squamous cell carcinoma":1,
"hyperoside":1,
"survivin":1,
"Surgical procedures, operative":2,
"Robotics":1,
"Thyroid diseases":2,
"Ablation techniques":1,
"Reoperative surgery":1,
"Surgical strategy":1,
"Endoscopy":1,
"Mouth":1,
"Neck dissection":5,
"Factor analysis, statistical":2,
"Lymphatic metastasis":2,
"Galectin-3":2,
"fine needle aspiration (FNAC)":1,
"Antibody clones":1,
"CD43":1,
"Non-hematologic malignancies":1,
"B-cell lymphoma-2":1,
"Bcl-2-associated X protein":1,
"Prunella vulgaris":1,
"anti-proliferative":1,
"caspase-3":1,
"well-differentiated thyroid carcinoma":1,
"Pleural angiosarcoma":1,
"Radiometabolic therapy":1,
"Ethnicity":1,
"insurance coverage":1,
"Cancer registry":1,
"China":1,
"Bavaria":1,
"groundwater":1,
"liver":1,
"odds ratio":1,
"public health":1,
"relative risk":1,
"uranium":1,
"RAI (radioiodine) ablation":1,
"molecular diagnostics":1,
"multi kinase inhibitors":1,
"thyroid surgery":4,
"Graves′ disease":1,
"Hashimoto disease":1,
"Thyroid imaging reporting and data system":1,
"Utrasonography":1,
"Tumor recurrence":1,
"Kindler's syndrome, Breast Cancer, Oman, The Royal Hospital, BC, KS":1,
"Intracystic growth":1,
"Mesonephric adenocarcinoma":1,
"Uterine corpus":1,
"RET proto-oncogene":1,
"microRNA-323":1,
"FFPE":1,
"CD133 antigen":1,
"Phosphoinositide-3-kinase":1,
"Sodium":1,
"iodide symporter":1,
"Iran":1,
"cancer detection":1,
"hyperspectral imaging":1,
"image classification":1,
"image quantification":1,
"image-guided surgery":1,
"label-free":1,
"tumor margin assessment":1,
"ecological study":1,
"nuclear sites":1,
"acid-triggered release":1,
"doxorubicin":1,
"silicon dioxide nanoparticle":1,
"Drug repurposing":1,
"Ribavirin":1,
"eIF4E":1,
"β-catenin":1,
"VCAN":1,
"miR-135a-5p":1,
"Pentastomida":1,
"bisphosphonate-associated osteonecrosis of the jaw (BRONJ)":1,
"osteonecrosis":1,
"parasite":1,
"Adenoid cystic carcinoma":1,
"Trachea":3,
"Diagnostic agreement":1,
"Evidence based":1,
"Survival times":1,
"CT":1,
"Computed tomography":1,
"US":1,
"early detection of cancer":1,
"stage":1,
"Mutation burden":1,
"Neoantigen":1,
"Tumor microenvironment immune type":1,
"mRNA sequencing":1,
"Esophageal neuroendocrine carcinoma":1,
"esophageal carcinoid":1,
"esophageal neoplasm":1,
"neuroendocrine tumors":2,
"Anatomical anomaly":1,
"Lingual artery":1,
"Superior thyroid artery":1,
"Histology":2,
"Pathology":1,
"Dry mouth":1,
"Nuclear medicine imaging":1,
"Radioiodine treatment":1,
"Non-functional parathyroid carcinoma":1,
"double parathyroid carcinoma":1,
"thyroid papillary carcinoma":1,
"Pyruvate kinases isoenzyme M2":1,
"activator":1,
"carboxamide":1,
"phenolic compound":1,
"sulfonamide":1,
"Chemotherapy":2,
"cisplatin":1,
"etoposide":1,
"neuroendocrine tumor":2,
"IHC":1,
"CXXC5":1,
"chromogenic in&nbsp":1,
"situ hybridization":1,
"high-grade prostatic intra-epithelial neoplasia":1,
"proliferative inflammatory atrophy":1,
"prostatic adenocarcinoma":1,
"BRCAlike":1,
"DDR":1,
"HR":1,
"PARPi":1,
"TKi":1,
"synthetic-lethal":1,
"targeted-therapy":1,
"PSM":3,
"SEER":3,
"oxyphilic cell papillary thyroid carcinoma":1,
"circulating epithelial cells":1,
"epithelial cell adhesion molecule":1,
"podoplanin":1,
"therapeutic response":1,
"risk factors":3,
"liver transplantation":1,
"selection":1,
"transarterial chemoembolization":1,
"Graves Disease":1,
"functional thyroid carcinoma":1,
"cN0":1,
"spectral Doppler":1,
"superb microvascular imaging":1,
"shear wave elastography":1,
"carotid sheath":1,
"99mTc-sestamibi":1,
"Parathyroid carcinoma":1,
"SPECT/CT":1,
"Colon cancer":1,
"Virchow lymph node dissection":1,
"Virchow lymph node metastasis":1,
"cytokeratin 19":1,
"diagnostic accuracy":1,
"hector battiforamesothelial antigen-1":1,
"Ectopic thyroid tissue":1,
"adrenal gland":1,
"immnunohistochemistry":1,
"serum miR-26a":1,
"Hypocalcemia":1,
"Hypoparathyroidism":3,
"Parathyroid hormone":1,
"Vitamin D":3,
"carbon nanoparticles":1,
"clinical lymph node metastasis":1,
"parathyroid":2,
"stochastic control":1,
"Tc99m sestamibi scintigraphy":1,
"thyroid disorder":1,
"thyroid pathology":1,
"CD34":1,
"Myofibroblasts":1,
"Regeneration":1,
"Repair":1,
"Stromal cells":1,
"Telocyte hyperplasia":1,
"Telocytehyperplasia":1,
"Tumour stroma":1,
"FTO":1,
"rs9939609":1,
"ectopic":1,
"retrosternal":1,
"Intraoperative neuromonitoring":1,
"Prognostic value":2,
"Staged thyroidectomy":1,
"DNA and RNA techniques":1,
"tumour markers":1,
"Congenital cystic lesions":1,
"Pax8":1,
"Black thyroid":1,
"Fluorescence imaging":1,
"Indocyanine green":1,
"Minocycline":1,
"Thyroid pigment":1,
"AFTN":1,
"Ultrasound-guided procedures":1,
"FOXP3":1,
"single nucleotide polymorphism":1,
"Cost effectiveness":1,
"Decision analysis":1,
"Oral hamartomas":1,
"Oral papules":1,
"Children":3,
"pediatric thyroid cancer":1,
"puberty BRAF mutation":1,
"Bone":1,
"Cementoplasty":1,
"Interventional oncology":1,
"Stent":1,
"Cancer stem cells":1,
"GANT61":1,
"Hedgehog pathway":1,
"Paclitaxel":1,
"Triple-negative breast cancer":2,
"Clinical implication":1,
"Computer-assisted interventions":1,
"Electromagnetic tracking":1,
"Gelatin phantoms":1,
"Aberrant surgical anatomy":1,
"Clinical case":1,
"Neck surgery":1,
"Right subclavian artery":1,
"HIF-1α":1,
"Hyperinsulinemia":1,
"Type 2 diabetes mellitus":1,
"Endoscopic parathyroidectomy":1,
"Focused parathyroidectomy":1,
"Minimally invasive parathyroid surgery":1,
"delayed recovery":1,
"dynamic risk stratification":1,
"thyrotrophin":1,
"CD70":1,
"PDL1":1,
"frozen section fine-needle aspiration biopsy":1,
"catechol estrogen-3,4-quinones":1,
"depurinating DNA adducts":1,
"dopamine 3,4-quinone":1,
"ABCG2":1,
"MRP1":1,
"NSCLC":1,
"Screening criteria":1,
"Smoking":1,
"Survivor":1,
"incidental findings":1,
"low-dose computed tomographic scans":1,
"lung cancer screening":1,
"Oncogene":1,
"ZCCHC12":1,
"111In-octreotide":1,
"Asian populations":1,
"cohort study":2,
"immigrants":1,
"Acral melanoma":1,
"papillary carcinoma thyroid":1,
"warthin-like papillary carcinoma of thyroid":1,
"acoustic radiation force impulse":1,
"Cancer predisposition syndrome":1,
"Cystic nephroma":1,
"DICER1":1,
"Pineoblastoma":1,
"Atypia or follicular lesion of undetermined significance":1,
"Subclassification":1,
"Hashimoto's disease":1,
"Anti-thyroglobulin antibodies":1,
"Radioactive iodine ablation":1,
"microcarcinomas":1,
"surveillance for microcarcinomas":1,
"CT scans":1,
"cross-sectional anatomy":1,
"ethnic group":1,
"neck surface anatomy":1,
"cardiovascular disease":1,
"racial differences":1,
"survivorship":1,
"Afirma":1,
"gene expression classifier":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":2,
"dual malignancy":1,
"small lymphocytic lymphoma":1,
"thyroid fine needle aspiration":1,
"inflammation based score":1,
"plasma fibrinogen":1,
"platelet-to-lymphocyte ratio":1,
"prognostic nutritional index":1,
"reporting":1,
"HCC":1,
"dose finding":1,
"incidental lymph nodes":1,
"Intraoperative nerve monitoring":1,
"Recurrent laryngeal nerve injury":1,
"adenocarcinoma":1,
"dogs":1,
"lung neoplasms":1,
"napsin A":1,
"surfactant protein A":1,
"adolescents":1,
"apoplexy":1,
"headache magnetic resonance imaging":1,
"panhypopituitarism":1,
"pituitary abscess":1,
"Locoregional recurrence":1,
"intraoperative frozen section":1,
"Calcium signaling":1,
"Cytoskeleton":1,
"Gene expression":1,
"Human health risk assessment":1,
"Mode of action":1,
"extranodal extension":1,
"prognostic factor":1,
"cardiac death":1,
"cardiac disease":1,
"Remnant ablation":2,
"ThyroSeq":1,
"cytomorphology":1,
"fine-needle aspiration (FNA)":1,
"parathyroid hormone (PTH)":1,
"Tongue base":1,
"Transoral robotic surgery":1,
"FDG-PET":1,
"differential diagnosis":1,
"malignant tumours":1,
"sialadenoma papilliferum":1,
"Phase II clinical trial":1,
"overall survival":1,
"progression-free survival":2,
"validation studies":1,
"Cytohistological correlation":1,
"Cytological variants":1,
"MEN2":1,
"RET gene":1,
"Synonymous mutation":1,
"Fear of recurrence":1,
"Health-related quality of life":1,
"Patient Reported Outcomes":1,
"CASC2":1,
"Long noncoding RNAs":1,
"Carcinoma Hürthle cell carcinoma":1,
"Follicular carcinoma":2,
"Long noncoding RNA":1,
"MALAT1":1,
"Oncocytic":1,
"P-mTOR":1,
"miR885-5p":1,
"Alkylating chemotherapeutic agent":1,
"MNNG":1,
"MicroRNA-181b":1,
"PARP1":1,
"Cervical lymph node metastasis":1,
"Ethanol ablation":1,
"Percutaneous ethanol injection therapy":1,
"Recurrent papillary thyroid carcinoma":1,
"Phase 3":1,
"multitargeted kinase inhibitor":1,
"Aberrant right subclavian artery":1,
"esophageal cancer":1,
"non-recurrent inferior laryngeal nerve":1,
"thoracoscopic esophagectomy":1,
"quality assurance":1,
"Chromophobe renal cell carcinoma":1,
"Oncocytic carcinoma":1,
"Poorly differentiated carcinoma":1,
"Tuberous sclerosis complex":1,
"Breast disease":1,
"Flow cytometry":1,
"MALT":1,
"Thyroid lymphoma":1,
"κ/λ light chain ratio":1,
"Hashimoto’s thyroiditis":4,
"environment":1,
"Liver cancer":1,
"non-Hodgkin lymphoma":1,
"second malignant neoplasm":1,
"Bethesda classification":1,
"Frozen section":1,
"Indeterminate cytology":1,
"parotitis":1,
"sialoendoscopy":1,
"Akt-mTOR":1,
"MREG":1,
"Minimally invasive extrathyroidal growth":1,
"Prognostic relevance":1,
"Residual tumor":1,
"TNM classification":1,
"ATA":1,
"K-TIRADS":1,
"follicular variant of papillary thyroid carcinoma":1,
"disease recurrence":1,
"low risk":1,
"thyrotropin suppressive therapy":1,
"drug development":1,
"cancer survivorship":1,
"fatigue":1,
"physical activity":1,
"BSRTC":1,
"Bethesda System for Reporting Thyroid Cytopathology":1,
"atypia of undetermined significance or follicular lesion of undetermined significance":1,
"Acinar":1,
"Galectin-4":1,
"Autoimmune thyroid diseases":1,
"Hyperprolactinemia":1,
"Prolactin":1,
"Prolactinoma":1,
"Branchial arch":1,
"Solid cell nest":1,
"Ultimobranchial body":1,
"Warthin tumor":1,
"Laparoscopic splenectomy":1,
"solitary splenic metastasis":1,
"clinical research":1,
"thyroid cancer — clinical":1,
"Retrospective study":1,
"TGF-β1":2,
"Triple negative breast cancer":1,
"Two-institutional":1,
"Enzyme-Linked Immunosorbent Assay":1,
"KLLN protein":1,
"PTEN protein":1,
"FNA":1,
"Nodule":1,
"I-131":1,
"I-131 adjuvant treatment":1,
"Radioiodine refractory disease":1,
"Radioiodine scanning":1,
"Micronutrient deficiency":1,
"Vitamin E":1,
"Zinc":1,
"Null cell adenoma":1,
"Pituitary neuroendocrine tumor":1,
"Silent subtype III adenoma":1,
"Chemoradiotherapy":1,
"Hyper fractionated radiotherapy":1,
"Pancreatic cancer":1,
"Proton beam radiotherapy":1,
"Unresectable cancer":1,
"Warburg effect":1,
"cancer biology":1,
"cancer metabolism":1,
"cancer therapy":1,
"energy metabolism":1,
"mitochondrial oxidative phosphorylation":1,
"pyruvate kinase M1":1,
"pyruvate kinase M2":1,
"ATA guideline":1,
"disease presentation":1,
"risk stratification":1,
"HBV/HCV reactivation":1,
"Hepatitis B virus (HBV)":1,
"Hepatitis C virus (HCV)":1,
"Toxicity":1,
"dabrafenib":1,
"intermittent dosing":1,
"trametinib":2,
"bronchogenic carcinoma":1,
"carcinoid syndrome":1,
"carcinoid tumor":2,
"flushing":1,
"gastroenteropancreatic neuroendocrine tumor":1,
"mastocytosis":1,
"pheochromocytoma":2,
"vasointestinal polypeptide–secreting tumor":1,
"Cardiotoxicity":1,
"Sensitivity":1,
"Molecular testing":1,
"Secretory carcinoma of thyroid":1,
"Signet ring cells":1,
"Metabolism":1,
"Lymphangiogenesis":1,
"Ovarian carcinomas":1,
"Microwave ablation":1,
"nodule volume":1,
"reduction rate":1,
"thyroid function":1,
"iodine theranostics":1,
"redifferentiation":1,
"sodium–iodine symporter":1,
"PRRT":1,
"absorbed dose":1,
"radiobiology":1,
"theranostics":1,
"Oral cancer":1,
"Patient-reported outcome":1,
"Speech":1,
"Stereotactic radiosurgery":1,
"brain metastases":1,
"long-term survival":1,
"Metallothioneins":1,
"Splicing":1,
"miR17-92 cluster":1,
"miRNA":1,
"Thyroid neoplasm, carcinoma, papillary":1,
"thyroid peroxidase":1,
"adrenal disorders":1,
"clinical practice guideline":1,
"neck cancer":1,
"Breast invasive ductal carcinoma":1,
"Clinical characteristics":1,
"Programmed death 1 ligand 1":1,
"autoimmune thyroid disease":1,
"Biopsy, fine needle":1,
"Gene":1,
"Mutation":1,
"Malignant glomus tumor":1,
"Advanced stage":1,
"Deltopectoral flap":1,
"Reconstruction":1,
"Calcinosis circumscripta":1,
"Panthera leo":1,
"lion":1,
"skin":1,
"tumoral calcinosis":1,
"Aesthetic principle":1,
"Minimally invasive access":1,
"POSAS":1,
"Antenatal, Antithyroid drug, Hyperthyroidism, Hypothyroidism, Thyroid cancer, Thyroid nodules, Lactation":1,
"anastomosis":1,
"circumferential sleeve resection":1,
"suprahyoid release":1,
"lysosome-associated protein transmembrane 4-β":1,
"susceptibility":1,
"transcription activity":1,
"nodular thyroid":1,
"ultrasound elastography":1,
"C-X-C chemokine receptor type 7":1,
"isobaric tag for relative and absolute quantification-coupled two-dimensional liquid chromatography-tandem mass spectrometry analysis":1,
"bromocriptine":1,
"resistance to thyroid hormone":1,
"C-cells":1,
"Calcitonin receptor":1,
"Vandetinib":1,
"Nano-diamino-tetrac":1,
"antiproliferation":1,
"tetrac":1,
"Clinical oncology":1,
"Endocrine surgery":1,
"Thyroid disorders":1,
"C634Y":1,
"D707E":1,
"MEN2A":1,
"double mutation":1,
"Hürthle cell neoplasm":1,
"thyroid follicular neoplasm":1,
"unwanted effects / adverse reactions":1,
"Goiter, nodular":1,
"Tomography, X-ray computed":1,
"CASTLE":1,
"case report":2,
"radiation therapy":1,
"BET protein inhibitors":1,
"BET proteins":1,
"Chromatin modifications":1,
"Epigenomics":1,
"Histone deacetylase inhibitors":1,
"Histone deacetylases":1,
"JQ1":1,
"Breast neoplasms":1,
"Consensus":1,
"Interdisciplinary communication":1,
"fine-needle aspirates":1,
"intraoperative thyroglobulin measurement":1,
"preoperative ultrasonography":1,
"predictive factors":1,
"recurrent laryngeal nerve invasion":1,
"Chromogranin A":1,
"Markers, Tumor":1,
"Europe":1,
"Population-based cancer registry":1,
"Rare cancers":1,
"MTC":1,
"RAS":1,
"RET":1,
"Eosinophil cationic protein":1,
"Interleukin 5":1,
"AR42J cell":1,
"Aminoguanidine":1,
"MAPK signaling":1,
"cell function":1,
"effect on mechanisms":1,
"lipid peroxidation":1,
"Granuloma":1,
"Nocardia":1,
"Post-thyroidectomy thyroid storm":1,
"Thyrotropin receptor antibodies":1,
"PD-L1":1,
"TIL":1,
"TNBC":1,
"Notch3":1,
"epithelial-mesenchymal transition":1,
"luminal phenotype":1,
"Breast tumor":1,
"Papillary breast carcinoma":1,
"BRAFV600E":1,
"chromosome 5":1,
"combined therapy with vemurafenib and palbociclib":1,
"papillary thyroid cancer preclinical model":1,
"mixed subtype thyroid carcinoma":1,
"Autopsy":1,
"Diagnostic techniques and procedures":1,
"X-linked inhibitor of apoptosis protein (XIAP)":1,
"anaplastic thyroid carcinoma (ATC)":1,
"oxyphilic thyroid carcinoma":1,
"child":1,
"MCL-1":1,
"TRAIL":1,
"c-met":1,
"miR-101":1,
"ASD: Autism spectrum disorder":1,
"ATP: Adenosine triphosphate":1,
"ENCoM: Elastic network contact model":1,
"GROMACS: Groningen machine for chemical simulations":1,
"LINCS: Linear constraint solver":1,
"MD: Molecular dynamics":1,
"NMA: Normal mode analysis":1,
"PCA: Principal component analysis":1,
"PDB: Protein data bank":1,
"PHTS: hamartoma tumor syndrome":1,
"PIP: Phosphatidylinositol-3,4,5-triphosphate":1,
"PIP: Phosphatidylinositol-4,5-biphosphate":1,
"PME: Particle mesh Ewald":1,
"PTEN: Phosphatase and tensin homolog deleted on chromosome ten":1,
"RMSD: Root mean square deviation":1,
"Rg: Radius of gyration":1,
"VMD: Visual Molecular Dynamics":1,
"WT: Wild-type":1,
"autism":1,
"molecular dynamics simulations":1,
"poly(Glu-pTyr): Polymers of glutamate and tyrosine, 1:1 ratio":1,
"protein structure stability":1,
"Chinese population":1,
"cancer susceptibility genes":1,
"germline mutations":1,
"multiple-gene sequencing":1,
"clincopathological character":1,
"conventional thyroidectomy":1,
"effectiveness":1,
"minimally invasive video-assisted thyroidectomy":1,
"safety":1,
"recurrent laryngeal nerve palsy":1,
"postoperative pain":1,
"IQGAP":1,
"Axillary lymph nodes":1,
"Ki-67":1,
"Luminal B HER-2 negative":1,
"PR status":1,
"Prognostic index":1,
"circulating tumor cell":1,
"follicular adenoma":1,
"peripheral blood":1,
"Bone and soft tissue":1,
"Soft tissue":1,
"Afirma gene expression classifier":1,
"Follicular variant of papillary&nbsp":1,
"thyroid carcinoma&nbsp":1,
"(FVPTC)":1,
"Noninvasive follicular thyroid&nbsp":1,
"neoplasm with papillary-like nuclear features&nbsp":1,
"(NIFTP)":1,
"Thyroid fine needle aspiration (FNA)":1,
"HePTP":1,
"Wnt/β-catenin":1,
"chemokine":1,
"cytokine":1,
"BANCR":1,
"Luteolin":1,
"TSHR":1,
"Papillary thyroglossal duct carcinoma":1,
"head and neck neoplasms":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年第3季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
